The efficacy and safety of Apatinib as Neoadjuvant Therapy in locally advanced differentiated thyroid carcinoma
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Rivoceranib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 20 Nov 2017 New trial record